<ul><li>ZAP Surgical Systems has closed a $78 million funding round to advance the commercialization of its ZAP-X Gyroscopic Radiosurgery platform.</li><li>The ZAP-X platform is a non-invasive cranial radiosurgery system that allows for precise tumor targeting and aims to preserve patient cognitive function.</li><li>The funding will help make stereotactic radiosurgery (SRS) more accessible to patients, as the cost and complexity of current technologies limit its use.</li><li>ZAP Surgical Systems' partnership with Baheal Medical, a leading healthcare company in China, will further expand access to the ZAP-X platform.</li></ul>

ZAP Surgical Systems obtains $78M to commercialize gyroscopic radiosurgery platform

Discover more